An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease.
Sandborn
William J
WJ
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street NW, Rochester, MN 55905, USA.
Hanauer
Stephen
S
Loftus
Edward V
EV
Tremaine
William J
WJ
Kane
Sunanda
S
Cohen
Russell
R
Hanson
Karen
K
Johnson
Therese
T
Schmitt
Debra
D
Jeche
Resa
R
D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000188:drug therapy*; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D010865:Pilot Projects; D014409:Tumor Necrosis Factor-alpha
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab